Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification

Cytotherapies are often necessary for the management of symptomatic large knee (osteo)-chondral defects. While autologous chondrocyte implantation (ACI) has been clinically used for 30 years, allogeneic cells (clinical-grade FE002 primary chondroprogenitors) have been investigated in translational s...

Descripción completa

Detalles Bibliográficos
Autores principales: Philippe, Virginie, Jeannerat, Annick, Peneveyre, Cédric, Jaccoud, Sandra, Scaletta, Corinne, Hirt-Burri, Nathalie, Abdel-Sayed, Philippe, Raffoul, Wassim, Darwiche, Salim, Applegate, Lee Ann, Martin, Robin, Laurent, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536774/
https://www.ncbi.nlm.nih.gov/pubmed/37765301
http://dx.doi.org/10.3390/pharmaceutics15092333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536774/
https://www.ncbi.nlm.nih.gov/pubmed/37765301
http://dx.doi.org/10.3390/pharmaceutics15092333

Ejemplares similares